Figure 4 | Scientific Reports

Figure 4

From: Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease

Figure 4

Association between LPC(14:0) and patient background characteristics. (A) Multivariable logistic regression analysis of the characteristic contribution to plasma LPC concentrations. (B) Plasma LPC(14:0) concentrations with BMI. (C) BMI-adjusted plasma LPC(14:0) concentrations in acute and recovery phase DILD and DILD-tolerant patients. ***p < 0.001 vs. acute phase. (D) ROC curve of BMI-adjusted LPC(14:0) concentrations between acute and recovery phase DILD patients. (E) ROC curve of BMI-adjusted LPC(14:0) between acute phase and DILD-tolerant patients.

Back to article page